← Leaderboards
Malcolm A Leissring
Brigham And Women'S Hospital
$5,920,046
Attributed
$5,920,046
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $789.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,920,046 · 7
By mechanism
R01$4,355,151 · 2
R21$1,539,895 · 4
R03$25,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Robert M. Friedlander$14,236,800
- James Kuang-Jan Liao$22,168,806
- Joseph Loscalzo$36,255,197
- Hamid Band$15,640,616
- Thomas Michel$27,999,083
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPeptide HydrolasesLeadCellsS DiseaseProteinsExtracellularCerebrumMutationPathogenesisInsulinaseBaseInnovationAmyloidExperimental StudyInsightS Disease RiskInterestBlood - Brain Barrier AnatomyDefectInhibitor/AntagonistAmyloid Beta-ProteinGeneticAnimal Model
Grant awards (19)
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease$541,947
R01 · FY2025 · AG · contact PI
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease$622,244
R01 · FY2024 · AG · contact PI
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease$626,169
R01 · FY2023 · AG · contact PI
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease$543,137
R01 · FY2022 · AG · contact PI
A single-molecule protein nanocapsule for targeted delivery of diverse cargo$231,375
R21 · FY2022 · GM · contact PI
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease$583,548
R01 · FY2021 · AG · contact PI
A single-molecule protein nanocapsule for targeted delivery of diverse cargo$206,216
R21 · FY2021 · GM · contact PI
Zinc-targeting inhibitors of insulin-degrading enzyme$286,100
R01 · FY2020 · GM · contact PI
Zinc-targeting inhibitors of insulin-degrading enzyme$286,916
R01 · FY2019 · GM · contact PI
Zinc-targeting inhibitors of insulin-degrading enzyme$287,675
R01 · FY2018 · GM · contact PI
Transient defects in Abeta catabolism in the etiology of sporadic Alzheimer disease$193,125
R21 · FY2018 · AG · contact PI
Zinc-targeting inhibitors of insulin-degrading enzyme$288,380
R01 · FY2017 · GM · contact PI
Transient defects in Abeta catabolism in the etiology of sporadic Alzheimer disease$231,750
R21 · FY2017 · AG · contact PI
Zinc-targeting inhibitors of insulin-degrading enzyme$289,035
R01 · FY2016 · GM · contact PI
High-throughput compound screening for modulators of insulin-degrading enzyme.$188,190
R21 · FY2009 · AG · contact PI
High-throughput compound screening for modulators of insulin-degrading enzyme.$156,825
R21 · FY2008 · AG · contact PI
HTS for Modulators of Beta-Amyloid Catabolism by Insulin-Degrading Enzyme$25,000
R03 · FY2007 · DA · contact PI
Peripheral Degradation of Amyloid Beta-Protein$166,352
R21 · FY2006 · AG · contact PI
Peripheral Degradation of Amyloid Beta-Protein$166,062
R21 · FY2005 · AG